Cargando…

Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation

Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Akitaka, Wada, Hideo, Ichkawa, Yuhuko, Tanaka, Motoko, Tashiro, Haruhiko, Shiraki, Katsuya, Shimpo, Hideto, Yamashita, Yoshiki, Mastumoto, Takeshi, Shimaoka, Motomu, Iba, Toshiaki, Suzuki-Inoue, Katsue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269023/ https://www.ncbi.nlm.nih.gov/pubmed/34203210 http://dx.doi.org/10.3390/jcm10132860

Ejemplares similares

Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2
por: Yamamoto, Akitaka, et al.
Publicado: (2023)

Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients
por: Ichkawa, Yuhuko, et al.
Publicado: (2020)

Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2022)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation
por: Wada, Hideo, et al.
Publicado: (2022)

Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction
por: Nishigaki, Akisato, et al.
Publicado: (2021)

Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura
por: Wada, Hideo, et al.
Publicado: (2021)

The Reevaluation of Thrombin Time Using a Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2021)

Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases
por: Ezaki, Minoru, et al.
Publicado: (2023)

D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases
por: Ikeda, Nozomi, et al.
Publicado: (2022)

Clot Waveform Analysis for Hemostatic Abnormalities
por: Wada, Hideo, et al.
Publicado: (2023)

A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms
por: Kobayashi, Mayu, et al.
Publicado: (2021)

A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab
por: Wada, Hideo, et al.
Publicado: (2022)

The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate
por: Matsumoto, Takeshi, et al.
Publicado: (2023)

The Detection of Hypercoagulability in Patients with Acute Cerebral Infarction Using a Clot Waveform Analysis
por: Kamon, Toshitaka, et al.
Publicado: (2023)

The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay
por: Wada, Hideo, et al.
Publicado: (2021)

Sepsis-associated disseminated intravascular coagulation and its differential diagnoses
por: Iba, Toshiaki, et al.
Publicado: (2019)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey
por: Iba, Toshiaki, et al.
Publicado: (2014)

Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
por: Wada, Hideo, et al.
Publicado: (2018)

Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection
por: Yamamoto, Akitaka, et al.
Publicado: (2021)

COVID-19 coagulopathy: is it disseminated intravascular coagulation?
por: Levi, Marcel, et al.
Publicado: (2020)

Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2019)

Update on the Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2020)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2015)

Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2016)

Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019)

Is early treatment of disseminated intravascular coagulation beneficial in septic patients?
por: Wada, Hideo, et al.
Publicado: (2014)

Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines
por: Wada, Hideo, et al.
Publicado: (2014)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity
por: Iba, Toshiaki, et al.
Publicado: (2016)

Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019)

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential
por: Ito, Takashi, et al.
Publicado: (2019)

COVID-19-associated coagulopathy and disseminated intravascular coagulation
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa
por: Kawasugi, Kazuo, et al.
Publicado: (2021)

Thrombomodulin: A Bifunctional Modulator of Inflammation and Coagulation in Sepsis
por: Okamoto, Takayuki, et al.
Publicado: (2012)

Disseminated intravascular coagulation or extended intravascular coagulation in massive pulmonary embolism
por: LEVI, M
Publicado: (2010)

Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i798im4te4a8ak3kh3g9nn9bb7